Sustained virologic response with ribavirin in chronic hepatitis E virus infection in heart transplantation

2011 ◽  
Vol 30 (7) ◽  
pp. 841-843 ◽  
Author(s):  
Antoine Chaillon ◽  
Agnès Sirinelli ◽  
Anne De Muret ◽  
Elisabeth Nicand ◽  
Louis d'Alteroche ◽  
...  
2017 ◽  
Vol 185 (2) ◽  
pp. 484-493 ◽  
Author(s):  
Halla Mohamed Ragab ◽  
Nabila Abd El Maksoud ◽  
Mona A. Amin ◽  
Mohab H. Halim ◽  
Nour A. Abdulla ◽  
...  

Hepatology ◽  
2014 ◽  
Vol 60 (3) ◽  
pp. 1112-1113 ◽  
Author(s):  
Christoph Höner zu Siederdissen ◽  
Sven Pischke ◽  
Jerome Schlue ◽  
Katja Deterding ◽  
Timo Hellms ◽  
...  

2019 ◽  
Vol 6 (9) ◽  
Author(s):  
Caroline Protin ◽  
Florence Abravanel ◽  
Laurent Alric ◽  
Suzanne Tavitian ◽  
Lucie Obéric ◽  
...  

Abstract Ibrutinib is an oral first-in-class Bruton’s tyrosine kinase inhibitor approved for the therapy of various B-cell lymphoid malignancies. Among ibrutinib-related infections, viral hepatitis are poorly described. We report our single-center experience with 4 cases of chronic hepatitis E virus infection and their management with ribavirin.


2020 ◽  
Vol 104 (2) ◽  
pp. 437-444 ◽  
Author(s):  
Yohei Owada ◽  
Yukio Oshiro ◽  
Yuki Inagaki ◽  
Hiroshi Harada ◽  
Nobuhiro Fujiyama ◽  
...  

2020 ◽  
Vol 73 ◽  
pp. S855-S856
Author(s):  
Midas Mulder ◽  
Robert De Man ◽  
Nassim Kamar ◽  
Gülcan Durmaz ◽  
Joep de Bruijne ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document